Skip Navigation


Rheumatology Advance Access originally published online on March 17, 2008
Rheumatology 2008 47(5):731-732; doi:10.1093/rheumatology/ken091
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/731    most recent
ken091v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cobo-Ibáñez, T.
Right arrow Articles by Martín-Mola, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cobo-Ibáñez, T.
Right arrow Articles by Martín-Mola, E.
Related Collections
Right arrow Spondylarthropathies
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Do TNF-blockers reduce or induce uveitis?

T. Cobo-Ibáñez1, M. del Carmen Ordóñez1, S. Muñoz-Fernández1, R. Madero-Prado2 and E. Martín-Mola1

1Department of Rheumatology and 2Department of Biostatistics, Hospital Universitario La Paz, Madrid, Spain.

Correspondence to: T. Cobo-Ibáñez, Department of Rheumatology, Hospital Universitario La Paz. Po Castellana 261. 28046 Madrid, Spain. E-mail: tcoboiba@yahoo.es

The first 10% of the full text of this article appears below.

SIR, Uveitis is a well-known manifestation of SpAs that may lead to functional impairment. TNF-blockers are effective for treating SpA-related uveitis flares [1], but recent retrospective studies support the possibility of differential TNF-blockers effectiveness, with infliximab or adalimumab showing a higher efficacy than etanercept in the treatment of uveitis [2–4]. In addition, Lim et al. [5] have recently published the finding that etanercept may induce new uveitis flares. During the last 2 years, we have conducted a study with the objective of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?